At ESCMID Global 2025, Infectious Disease Frontier sat down with Dr. Francesco Cogliati Dezza to discuss the renewed clinical relevance of temocillin. As resistance to broad-spectrum antibiotics continues to rise, temocillin is emerging as a potent carbapenem-sparing agent, especially against multidrug-resistant Enterobacterales. Dr. Cogliati Dezza emphasized its role in responsible antimicrobial stewardship and the importance of re-evaluating older antibiotics in the fight against AMR.
